Silcock Edward
Known title: EVP & President, North AmericaCIK: 0001916700
Associated companies
Transaction History
| NATR | ▲ Buy | Grant | 15,909 | $0 | 7/21/2022 | View on chart |
| NATR | ▲ Buy | Option Exercise | 2,716 | — | 4/6/2022 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 662 | $11K | 4/6/2022 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 855 | $15K | 4/1/2022 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 829 | $0 | 3/30/2022 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 776 | $13K | 3/26/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Nature's Sunshine Q2 Earnings Reviewed Against Peers
A recent analysis compared Nature's Sunshine's second-quarter results with other personal care companies. This review helps investors understand how the stock performed relative to its sector during that period. The company currently trades with a trailing P/E ratio of 13.3, while analysts maintain an average price target of $30.50.
Nature's Sunshine Q2 Earnings Reviewed Against Peers. A recent analysis compared Nature's Sunshine's second-quarter results with other personal care companies. This review helps investors understand how the stock performed relative to its sector during that period. The company currently trades with a trailing P/E ratio of 13.3, while analysts maintain an average price target of $30.50.